1. Home
  2. WRBY vs VERA Comparison

WRBY vs VERA Comparison

Compare WRBY & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$24.18

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$53.58

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
VERA
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.5B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
WRBY
VERA
Price
$24.18
$53.58
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$25.43
$76.60
AVG Volume (30 Days)
5.6M
1.9M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$850,580,000.00
N/A
Revenue This Year
$15.47
N/A
Revenue Next Year
$13.06
N/A
P/E Ratio
$10,595.57
N/A
Revenue Growth
14.55
N/A
52 Week Low
$13.63
$18.53
52 Week High
$31.00
$56.05

Technical Indicators

Market Signals
Indicator
WRBY
VERA
Relative Strength Index (RSI) 52.54 80.23
Support Level $25.71 $47.22
Resistance Level $27.29 $56.05
Average True Range (ATR) 2.11 2.89
MACD -0.12 0.39
Stochastic Oscillator 41.78 85.61

Price Performance

Historical Comparison
WRBY
VERA

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: